Skip to content
Wired1 min read

FDA Approves Eli Lilly's GLP-1 Pill

Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
Read original on wired.com
0
0

Comment

Sign in to join the discussion.

Loading comments…

Related

Get the 10 best reads every Sunday

Curated by AI, voted by readers. Free forever.

Liked this? Start your own feed.

0
0